Health Care

Coronavirus

Dr. Henry Miller – Is a Covid-19 Vaccine Really Just Around the Corner?

Dr. Henry Miller, PRI senior fellow in health care studies and former founding director of the FDA’s Office of Biotechnology, joins us with an update on efforts to develop vaccines and therapeutics to fight Covid-19.  He discusses how a transition between two presidential administrations will affect the work of the ...
Commentary

Three Healthcare Achievements To Be Thankful For

Thanksgiving is this Thursday. It may seem hard to believe, but even in this year unlike any other, there’s still plenty to be thankful for—including some notable developments in healthcare policy. *** 1. Individual health insurance premiums have stabilized and declined. Open enrollment on the HealthCare.gov exchanges run by the ...
Commentary

The Street Interviews Dr. Henry Miller on Pfizer COVID-19 Vaccine

Shots Heard ‘Round the World: Will Pfizer, Moderna Vaccines Start End of Pandemic? By Adam Smith, The Street The U.S. found itself this month both in the most dangerous stage of the Covid-19 pandemic to date, and in the most hopeful stage. Just as the daily case counts of new ...
Coronavirus

Dr. Henry Miller Talks FDA Vaccine Approval Process for COVID-19

Dr. Henry Miller joins the John Batchelor Show for his weekly conversation about the coronavirus and COVID-19 vaccine. Miller and Batchelor discuss the Pfizer declaration for an emergency track and approval with the FDA to begin distributing a vaccine for treatment against the novel coronavirus. Miller shares his 15 years ...
Commentary

AOC’s ‘path forward’ on healthcare is just a giant step back

On Wednesday, Democratic Reps. Alexandria Ocasio-Cortez, Katie Porter, and Pramila Jayapal joined former insurance industry executive and now “Medicare for all” advocate Wendell Potter in an online strategy session to “chart the path forward” for health reform under a Biden administration. The trio of liberal lawmakers pressed ahead with their demand for ...
Commentary

Trump wrongly attacks life-saving drug companies on coronavirus vaccines and more

President Trump announced Friday that he will proceed with his plans to peg the prices of certain drugs prescribed largely at doctors’ offices under Medicare Part B to the lower prices that other developed nations pay for those drugs. That may sound good at first glance, but in reality, the move will slow ...
Blog

California’s Unexpected Surplus Further Proof Bailout for States Unnecessary

Last week, the nonpartisan Legislative Analyst’s office (LAO) released its fiscal outlook for 2021, which is traditionally the start of the debate over next year’s state budget. Unexpectedly, California finds itself sitting on a $26 billion windfall according to the LAO, attributed to “results from revisions in prior- and current-year ...
Commentary

Unnecessary State Reviews of COVID-19 Vaccines Could Delay Distribution

By John J. Cohrssen and Henry I. Miller We are in the midst of a pandemic of historic proportions. COVID-19 has killed more than a quarter of a million Americans, caused pain and suffering to many more, damaged a thriving economy, and caused great public anxiety. And it promises to get ...
Business & Economics

Wayne Winegarden Quoted in COVID-19 Stimulus Article

Majority of Voters Think Coronavirus Stimulus Package Should Be Top Priority During Biden’s First 100 Days By Rachel Bucchino Amajority of registered voters think President-elect Joe Biden should focus on issues relating to tackling the coronavirus pandemic and a strained economy during his first 100 days in the White House, ...
Commentary

What uninsured crisis?

Roughly 30 million Americans lack health insurance, according to a new report from the Congressional Budget Office. But there’s more to that 30-million figure than meets the eye. The majority are more or less uninsured by choice. Getting those folks covered can be done for a lot less than the hundreds of ...
Coronavirus

Dr. Henry Miller – Is a Covid-19 Vaccine Really Just Around the Corner?

Dr. Henry Miller, PRI senior fellow in health care studies and former founding director of the FDA’s Office of Biotechnology, joins us with an update on efforts to develop vaccines and therapeutics to fight Covid-19.  He discusses how a transition between two presidential administrations will affect the work of the ...
Commentary

Three Healthcare Achievements To Be Thankful For

Thanksgiving is this Thursday. It may seem hard to believe, but even in this year unlike any other, there’s still plenty to be thankful for—including some notable developments in healthcare policy. *** 1. Individual health insurance premiums have stabilized and declined. Open enrollment on the HealthCare.gov exchanges run by the ...
Commentary

The Street Interviews Dr. Henry Miller on Pfizer COVID-19 Vaccine

Shots Heard ‘Round the World: Will Pfizer, Moderna Vaccines Start End of Pandemic? By Adam Smith, The Street The U.S. found itself this month both in the most dangerous stage of the Covid-19 pandemic to date, and in the most hopeful stage. Just as the daily case counts of new ...
Coronavirus

Dr. Henry Miller Talks FDA Vaccine Approval Process for COVID-19

Dr. Henry Miller joins the John Batchelor Show for his weekly conversation about the coronavirus and COVID-19 vaccine. Miller and Batchelor discuss the Pfizer declaration for an emergency track and approval with the FDA to begin distributing a vaccine for treatment against the novel coronavirus. Miller shares his 15 years ...
Commentary

AOC’s ‘path forward’ on healthcare is just a giant step back

On Wednesday, Democratic Reps. Alexandria Ocasio-Cortez, Katie Porter, and Pramila Jayapal joined former insurance industry executive and now “Medicare for all” advocate Wendell Potter in an online strategy session to “chart the path forward” for health reform under a Biden administration. The trio of liberal lawmakers pressed ahead with their demand for ...
Commentary

Trump wrongly attacks life-saving drug companies on coronavirus vaccines and more

President Trump announced Friday that he will proceed with his plans to peg the prices of certain drugs prescribed largely at doctors’ offices under Medicare Part B to the lower prices that other developed nations pay for those drugs. That may sound good at first glance, but in reality, the move will slow ...
Blog

California’s Unexpected Surplus Further Proof Bailout for States Unnecessary

Last week, the nonpartisan Legislative Analyst’s office (LAO) released its fiscal outlook for 2021, which is traditionally the start of the debate over next year’s state budget. Unexpectedly, California finds itself sitting on a $26 billion windfall according to the LAO, attributed to “results from revisions in prior- and current-year ...
Commentary

Unnecessary State Reviews of COVID-19 Vaccines Could Delay Distribution

By John J. Cohrssen and Henry I. Miller We are in the midst of a pandemic of historic proportions. COVID-19 has killed more than a quarter of a million Americans, caused pain and suffering to many more, damaged a thriving economy, and caused great public anxiety. And it promises to get ...
Business & Economics

Wayne Winegarden Quoted in COVID-19 Stimulus Article

Majority of Voters Think Coronavirus Stimulus Package Should Be Top Priority During Biden’s First 100 Days By Rachel Bucchino Amajority of registered voters think President-elect Joe Biden should focus on issues relating to tackling the coronavirus pandemic and a strained economy during his first 100 days in the White House, ...
Commentary

What uninsured crisis?

Roughly 30 million Americans lack health insurance, according to a new report from the Congressional Budget Office. But there’s more to that 30-million figure than meets the eye. The majority are more or less uninsured by choice. Getting those folks covered can be done for a lot less than the hundreds of ...
Scroll to Top